Apple Faces Possible Import Ban on Certain Watch Models Over Patent Infringement

https://icaro.icaromediagroup.com/system/images/photos/15843668/original/open-uri20231027-56-32o62r?1698439434
ICARO Media Group
News
27/10/2023 20h43

In a recent development, Apple could potentially face an import ban on specific models of its Apple Watch due to a patent violation, according to reports from Gizmodo. The U.S. International Trade Commission has determined that Apple infringed on a patent held by medical-technology company Masimo, leading to potential consequences for the tech giant.

Masimo filed a complaint with the Commission in 2021, alleging that Apple copied its blood-oxygen measurement technology in the pulse oximeter of most new Apple Watch models since 2020, starting with the Series 6. The Commission concluded that this infringement was a violation of U.S. trade law, resulting in the issuance of a limited exclusion order. This order implies the possibility of an import ban on specific Apple Watch models being imported to the United States.

Apple has expressed its intention to appeal the agency's decision. The Biden administration now has 60 days to decide whether or not to veto the import ban before the ruling takes effect. In an effort to avoid the ban, Apple could explore options such as modifying the software to remove the disputed technology or negotiating a civil settlement with Masimo.

This is not the first legal battle between the two companies, as Masimo has previously accused Apple of stealing its technology and recruiting its employees. Masimo Chief Executive, Joe Kiani, stated, "Even the world's largest company is not above the law." Apple, on the other hand, claims that Masimo has attempted to use the ITC to hinder the availability of a potentially life-saving product for millions of U.S. consumers while introducing their own watch that allegedly copies Apple's design.

It is worth noting that Apple has faced similar allegations of technology theft in the past, with AliveCor accusing the company of stealing its health-sensing technology. However, Apple has rejected these allegations and has often argued that the patents at issue were overly broad. In the case of AliveCor's accusation, Apple was able to swiftly appeal and avoid any negative repercussions.

It remains to be seen how this legal dispute between Apple and Masimo will unfold, as both parties gear up for a potential legal battle. As technology continues to advance, intellectual property rights become crucial in the highly competitive tech industry. The outcome of this case could have significant implications not only for Apple but for future patent disputes in the field as well.

The views expressed in this article do not reflect the opinion of ICARO, or any of its affiliates.

Related